|
2025-04-11 |
2025-04-11 |
V
Vente
|
Anzalone Christopher Richard
Chief Executive Officer
Administrateur exécutif
|
50 800
-1.3%
11,49
583 692 USD
|
50 800
-1.3%
|
11,49
|
583 692 USD
|
|
|
2025-04-11 |
2025-04-10 |
V
Vente
|
Anzalone Christopher Richard
Chief Executive Officer
Administrateur exécutif
|
50 000
-1.2%
10,87
543 500 USD
|
50 000
-1.2%
|
10,87
|
543 500 USD
|
|
|
2025-04-11 |
2025-04-09 |
V
Vente
|
Anzalone Christopher Richard
Chief Executive Officer
Administrateur exécutif
|
1 617
-0.0%
11,76
19 016 USD
|
1 617
-0.0%
|
11,76
|
19 016 USD
|
|
|
2025-04-11 |
2025-04-09 |
V
Vente
|
Anzalone Christopher Richard
Chief Executive Officer
Administrateur exécutif
|
3 400
-0.1%
10,75
36 550 USD
|
3 400
-0.1%
|
10,75
|
36 550 USD
|
|
|
2025-04-11 |
2025-04-09 |
V
Vente
|
Anzalone Christopher Richard
Chief Executive Officer
Administrateur exécutif
|
35 305
-0.9%
9,93
350 579 USD
|
35 305
-0.9%
|
9,93
|
350 579 USD
|
|
|
2025-03-17 |
2025-03-13 |
V
Vente
|
Anzalone Christopher Richard
Chief Executive Officer
Administrateur exécutif
|
51 425
-1.3%
15,07
774 975 USD
|
51 425
-1.3%
|
15,07
|
774 975 USD
|
|
|
2025-03-05 |
2025-03-04 |
VP
Vente planifiée
|
Anzalone Christopher Richard
Chief Executive Officer
Administrateur exécutif
|
133 333
-3.4%
17,02
2 269 328 USD
|
133 333
-3.4%
|
17,02
|
2 269 328 USD
|
|
|
2025-03-05 |
2025-03-03 |
VP
Vente planifiée
|
Anzalone Christopher Richard
Chief Executive Officer
Administrateur exécutif
|
166 667
-4.1%
18,03
3 005 006 USD
|
166 667
-4.1%
|
18,03
|
3 005 006 USD
|
|
|
2025-01-27 |
2025-01-23 |
VP
Vente planifiée
|
OLUKOTUN ADEOYE Y
Administrateur non-exécutif
|
959
-2.6%
21,00
20 139 USD
|
959
-2.6%
|
21,00
|
20 139 USD
|
|
|
2025-01-07 |
2025-01-07 |
VP
Vente planifiée
|
O'Brien Patrick
COO and General Counsel
Dirigeant
|
8 000
-1.5%
19,69
157 520 USD
|
8 000
-1.5%
|
19,69
|
157 520 USD
|
|
|
2025-01-07 |
2025-01-07 |
V
Vente
|
Myszkowski Kenneth Allen
Chief Financial Officer
Dirigeant
|
10 000
-2.1%
19,69
196 900 USD
|
10 000
-2.1%
|
19,69
|
196 900 USD
|
|
|
2025-01-07 |
2025-01-07 |
VP
Vente planifiée
|
Myszkowski Kenneth Allen
Chief Financial Officer
Dirigeant
|
8 000
-1.7%
19,70
157 600 USD
|
8 000
-1.7%
|
19,70
|
157 600 USD
|
|
|
2025-01-07 |
2025-01-06 |
VP
Vente planifiée
|
O'Brien Patrick
COO and General Counsel
Dirigeant
|
9 526
-1.7%
20,10
191 473 USD
|
9 526
-1.7%
|
20,10
|
191 473 USD
|
|
|
2025-01-07 |
2025-01-06 |
VP
Vente planifiée
|
O'Brien Patrick
COO and General Counsel
Dirigeant
|
19 658
-3.5%
19,69
387 066 USD
|
19 658
-3.5%
|
19,69
|
387 066 USD
|
|
|
2025-01-07 |
2025-01-06 |
VP
Vente planifiée
|
Myszkowski Kenneth Allen
Chief Financial Officer
Dirigeant
|
9 402
-1.9%
20,10
188 980 USD
|
9 402
-1.9%
|
20,10
|
188 980 USD
|
|
|
2025-01-07 |
2025-01-06 |
VP
Vente planifiée
|
Myszkowski Kenneth Allen
Chief Financial Officer
Dirigeant
|
17 765
-3.5%
19,68
349 615 USD
|
17 765
-3.5%
|
19,68
|
349 615 USD
|
|
|
2025-01-07 |
2025-01-06 |
VP
Vente planifiée
|
Hamilton James C
Chief Discovery/Trans Medicine
Dirigeant
|
10 971
-3.9%
20,11
220 627 USD
|
10 971
-3.9%
|
20,11
|
220 627 USD
|
|
|
2025-01-07 |
2025-01-06 |
VP
Vente planifiée
|
Hamilton James C
Chief Discovery/Trans Medicine
Dirigeant
|
21 758
-7.1%
19,68
428 197 USD
|
21 758
-7.1%
|
19,68
|
428 197 USD
|
|
|
2025-01-06 |
2025-01-02 |
VP
Vente planifiée
|
Anzalone Christopher Richard
Chief Executive Officer
Administrateur exécutif
|
11 520
-0.3%
19,05
219 456 USD
|
11 520
-0.3%
|
19,05
|
219 456 USD
|
|
|
2024-12-30 |
2024-12-27 |
VP
Vente planifiée
|
OLUKOTUN ADEOYE Y
Administrateur non-exécutif
|
2 850
-7.2%
20,00
57 000 USD
|
2 850
-7.2%
|
20,00
|
57 000 USD
|
|
